A Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients With B-cell Lymphoproliferative Disorders

Clinical trial NCT06705530 · COMPLETED

Trial details

NCT number: NCT06705530
Sponsor: National Research Center for Hematology, Russia
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia ALL

Start date: 2024-11-26
Primary completion: 2025-10-17
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.